KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Goodwill (2016 - 2025)

Historic Goodwill for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to $18.3 billion.

  • Boston Scientific's Goodwill rose 698.11% to $18.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $18.3 billion, marking a year-over-year increase of 698.11%. This contributed to the annual value of $18.3 billion for FY2025, which is 698.11% up from last year.
  • Per Boston Scientific's latest filing, its Goodwill stood at $18.3 billion for Q4 2025, which was up 698.11% from $18.2 billion recorded in Q3 2025.
  • In the past 5 years, Boston Scientific's Goodwill ranged from a high of $18.3 billion in Q4 2025 and a low of $10.9 billion during Q1 2021
  • In the last 5 years, Boston Scientific's Goodwill had a median value of $13.6 billion in 2023 and averaged $14.2 billion.
  • Its Goodwill has fluctuated over the past 5 years, first skyrocketed by 247.12% in 2023, then soared by 2555.39% in 2025.
  • Over the past 5 years, Boston Scientific's Goodwill (Quarter) stood at $12.0 billion in 2021, then increased by 7.77% to $12.9 billion in 2022, then rose by 11.35% to $14.4 billion in 2023, then grew by 18.78% to $17.1 billion in 2024, then rose by 6.98% to $18.3 billion in 2025.
  • Its last three reported values are $18.3 billion in Q4 2025, $18.2 billion for Q3 2025, and $18.1 billion during Q2 2025.